These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Preliminary studies with citalopram (LU 10-171), a specific 5-HT-reuptake inhibitor, as antidepressant. Gastpar M; Gastpar G Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(3):319-25. PubMed ID: 6959196 [TBL] [Abstract][Full Text] [Related]
4. Initial, clinical trial of a new, specific 5-HT reuptake inhibitor, citalopram (Lu 10-171). Gottlieb P; Wandall T; Overø KF Acta Psychiatr Scand; 1980 Sep; 62(3):236-44. PubMed ID: 6935914 [TBL] [Abstract][Full Text] [Related]
9. Citalopram, a selective serotonin reuptake inhibitor: clinical antidepressive and long-term effect--a phase II study. Pedersen OL; Kragh-Sørensen P; Bjerre M; Overø KF; Gram LF Psychopharmacology (Berl); 1982; 77(3):199-204. PubMed ID: 6812140 [TBL] [Abstract][Full Text] [Related]
10. Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia. Sirota P; Mosheva T; Shabtay H; Giladi N; Korczyn AD Am J Psychiatry; 2000 Feb; 157(2):287-9. PubMed ID: 10671405 [TBL] [Abstract][Full Text] [Related]
11. Effects of serotonergic and anticholinergic drugs in haloperidol-induced dystonia in Cebus monkeys. Povlsen UJ; Noring U; Laursen AL; Korsgaard S; Gerlach J Clin Neuropharmacol; 1986; 9(1):84-90. PubMed ID: 3470140 [TBL] [Abstract][Full Text] [Related]
18. Effect of different neuroleptics in tardive dyskinesia and parkinsonism. A video-controlled multicenter study with chlorprothixene, perphenazine, haloperidol and haloperidol + biperiden. Nordic Dyskinesia Study Group. Psychopharmacology (Berl); 1986; 90(4):423-9. PubMed ID: 2880362 [TBL] [Abstract][Full Text] [Related]
19. Behavioral aspects of serotonin-dopamine interaction in the monkey. Korsgaard S; Gerlach J; Christensson E Eur J Pharmacol; 1985 Dec; 118(3):245-52. PubMed ID: 4085556 [TBL] [Abstract][Full Text] [Related]
20. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study. Bai YM; Yu SC; Lin CC J Clin Psychiatry; 2003 Nov; 64(11):1342-8. PubMed ID: 14658949 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]